SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • July 28th, 2022 • InvaGen Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS SHARE REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of this 25th day of July, 2022 (the “Execution Date”), by and among InvaGen Pharmaceuticals Inc., a New York corporation (“InvaGen”), Avenue Therapeutics, Inc., a Delaware corporation (“Avenue”), and Fortress Biotech, Inc., a Delaware corporation (“Fortress”). Each of InvaGen, Avenue and Fortress is a “Party,” and, collectively, they are the “Parties.”
